Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.7
3.9
Journals
JCM
Special Issues
Atrial Fibrillation and Arrhythmias: Symptoms, Diagnosis and Current Treatment
share announcement

Atrial Fibrillation and Arrhythmias: Symptoms, Diagnosis and Current Treatment

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 30 June 2024 | Viewed by 367

Special Issue Editor

Dr. Yoshifumi Ikeda

E-Mail Website
Guest Editor
Department of Cardiology, Saitama Medical University International Medical Center, Saitama 350-1298, Japan
Interests: atrial fibrillation; arrhythmias; cardiac implantable electric devices; cardiac resynchronization therapy; heart failure; remote monitoring; heart transplantation; palliative care

Special Issue Information

Dear Colleagues,

Electrophysiology in cardiology requires computer technology, and remarkable progress has been made in recent years. Some particularly noteworthy advancements have been made in ablation used as a treatment for atrial fibrillation, high-density 3D mapping and pulse fields, and catheters. In the future, there is a high expectation for combining diagnosis with AI. As computer technology continues to advance, we should expect continued advances in electrophysiological approaches to atrial fibrillation. We look forward to receiving your submissions of notable new discoveries in this field.

Dr. Yoshifumi Ikeda
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • atrial fibrillation
  • arrhythmias
  • cardiac implantable electric devices
  • cardiac resynchronization therapy
  • heart failure
  • remote monitoring
  • heart transplantation
  • palliative care

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

15 pages, 4325 KiB  
Article
Real-World Outcomes of a Rhythm Control Strategy for Atrial Fibrillation Patients with Reduced Left Ventricular Ejection Fraction (<50%)
by Ji-Hoon Choi and Chang Hee Kwon
J. Clin. Med. 2024, 13(11), 3285; https://doi.org/10.3390/jcm13113285 - 2 Jun 2024
Viewed by 180
Abstract
Background/Objectives: The effectiveness of a rhythm control strategy in patients with atrial fibrillation (AF) and reduced left ventricular ejection fraction (LVEF < 50%) in real-world practice remains uncertain. Our objective was to evaluate the real-world outcomes of a rhythm control strategy in [...] Read more.
Background/Objectives: The effectiveness of a rhythm control strategy in patients with atrial fibrillation (AF) and reduced left ventricular ejection fraction (LVEF < 50%) in real-world practice remains uncertain. Our objective was to evaluate the real-world outcomes of a rhythm control strategy in patients with AF and reduced LVEF, focusing on changes in LV systolic function and brain natriuretic peptide (BNP) levels. Methods: The study retrospectively reviewed the medical records of 80 patients with concurrent AF and reduced LVEF who underwent rhythm control therapy between March 2015 and December 2021. Results: The patients had an average age of 63.6 years and an initial LVEF of 34.3%. Sinus rhythm was restored using anti-arrhythmic drugs (38, 47.5%) or electrical cardioversion (42, 52.5%). Over a follow-up period of 53.0 months, AF recurred in 65% of patients, with 57.7% undergoing catheter ablation. Significant improvements were noted in LVEF (from 34.3% to 55.1%, p < 0.001) and BNP levels (from 752 pg/mL to 72 pg/mL, p < 0.001) at the last follow-up. Nearly all patients (97.5%) continued with the rhythm control strategy during the follow-up period. Conclusions: In real-world settings, a rhythm control strategy proves to be feasible and effective for improving LVEF and reducing BNP levels in AF patients with reduced LVEF. Full article
(This article belongs to the Special Issue Atrial Fibrillation and Arrhythmias: Symptoms, Diagnosis and Current Treatment)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop